Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 1 |
| Since 2017 (last 10 years) | 1 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Adults | 1 |
| Attention Deficit… | 1 |
| Correlation | 1 |
| Drug Therapy | 1 |
| Executive Function | 1 |
| Neurology | 1 |
| Outcomes of Treatment | 1 |
| Predictor Variables | 1 |
| Program Effectiveness | 1 |
| Short Term Memory | 1 |
| Stimulants | 1 |
| More ▼ | |
Source
| Journal of Attention Disorders | 1 |
Author
| Allison Green | 1 |
| Caroline Kelberman | 1 |
| James Capella | 1 |
| John D. E. Gabrieli | 1 |
| Joseph Biederman | 1 |
| Mai Uchida | 1 |
| Nicole Rudberg | 1 |
| Schuyler Gaillard | 1 |
| Yuwen Hung | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkYuwen Hung; Allison Green; Caroline Kelberman; Schuyler Gaillard; James Capella; Nicole Rudberg; John D. E. Gabrieli; Joseph Biederman; Mai Uchida – Journal of Attention Disorders, 2024
Objective: Stimulant medications are the main treatment for Attention Deficit Hyperactivity Disorder (ADHD), but overall treatment efficacy in adults has less than a 60% response rate. This study aimed to identify neural and cognitive markers predictive of longitudinal improvement in response to stimulant treatment in drug-naïve adults with ADHD.…
Descriptors: Stimulants, Drug Therapy, Attention Deficit Hyperactivity Disorder, Adults
